Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

First High-Definition Endoscopic Ultrasound (EUS) Technology Enhances Diagnostic Procedures
Physicians can now provide potentially safer and more accurate diagnostic procedures with the first and only high-definition endoscopic ultrasound (EUS) needle technology. Cook Medical, the only full-line supplier of endoscopic medical devices, has designed a complete line of high-definition EUS biopsy needles that are up to three-times brighter than others on the market. With the addition of the 19 and 25 gage EchoTip® Ultra with High Definition Fine Needle Aspiration (HDFNA™) needles, the EchoTip Ultra HDFNA represents the next level of precision in EUS, an essential diagnostic tool that yields more accurate images of the gastrointestinal (GI) tract than traditional ultrasound and provides minimally invasive access to areas that are traditionally difficult to reach.
generic viagra online
High-Cost Medicare Areas Worry About Looming Cuts
The White House"s pressure to cut soaring healthcare costs is causing action and concern in high cost Medicare areas, especially South Florida.
News of the day
US Oncology Research Network Participates In Phase III Follow-up Study To BiPar's Investigational Cancer Drug BSI-201
US Oncology, Inc. today announced that US Oncology Research will participate in the BiPar Sciences" Phase III, Multi-center, Open-Label, Randomized Trial of Gemcitabine/Carboplatin (G/C), with or without BSI-201, in patients with Estrogen Receptor (ER), Progesterone Receptor (PR), and HER2-negative metastatic breast cancer.
Sexual Health

Interactive Medica Launches Pharmaceutical Key Account Management SaaS Solution

Interactive Medica, the leading Pharma SaaS provider, today launches IM Strategic Selling, a new Software as a Service (SaaS) solution that enables promotional teams, managers and executives to identify, collaborate, plan and manage goals, strategies and activities for current and potential Key Accounts. The changing healthcare environment that Pharmaceutical companies face today is radically different from years gone by, companies who do not embrace the more collaborative, many to many, selling approach may find themselves left out of the key relationships required to sustain the use of their products. Being able to implement and manage a Key Account Plan is a pre-requisite for any Pharmaceutical company needing to communicate with multiple decision makers and stakeholders within the Health Service. "Many of the Pharmaceutical companies that Interactive Medica works with are looking at a Key Account Management approach but are put off by how complex it can appear, we felt that we could use our expertise to create a solution that makes this new sales approach far simpler. IM Strategic Selling supports this new complex method of selling by providing a wizard that helps and guides the sales team through this process making it far simpler to identify key actions or issues that need addressing." "IM Strategic Selling is platform independent allowing it to be used in conjunction with Pharmaceutical companies existing CRM and sales support applications enabling any Pharmaceutical sales team to benefit from the solution quickly and easily." "IM Strategic Selling allows our clients to co-ordinate a key account plan enabling them to orchestrate and allocate company res as efficiently as possible. Using IM Strategic Selling, our clients" account teams become focused on the overall opportunity, the relationships and res required to strategically expand the account." "Miller Heiman"s strategic selling model is one example of a business process that IM Strategic Selling is supporting however, we appreciate that every Pharmaceutical company is different and will adopt the specific model that fits their strategy. With IM Strategic Selling clients will be able to tailor the application to meet their exact business processes. " "We are very excited by IM Strategic Selling and the possibilities it can present to Pharmaceutical companies. " comments Richard Jenkinson, CEO of Interactive Medica. Database subscription RealWire aims to provide a targeted distribution through our RealWire service to editorial contacts. If you feel that releases received have not been well targeted and relevant to your areas of interest, please let us know and we will work to ensure this is corrected. If you wish to be unsubscribed, please reply to this release email and we will remove you immediately. Interactive Medica


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009